Medical devices, healthcare technology and the business of care
510(k) clearance · K263421

Veritas Shoulder System

restor3d Inc. · Decision date Oct 22, 2026

MEDTECHLEDGER EXPLANATIONK263421

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 10/22/2026 for the Veritas Shoulder System, submitted by restor3d, inc. of Durham, North Carolina, under 510(k) number K263421. The device falls under the classification name Shoulder Prosthesis, Reverse Configuration, regulation number 888.3660, with primary product code PHX and subsequent product codes HSD and QHE. The application was received 09/25/2026 and reviewed by the Orthopedic panel; the record lists a Special summary, no third-party review, no combination product status, and no authorized predetermined change control plan.

SESE denotes 510(k) clearance of substantial equivalence to a legally marketed predicate, not premarket approval of the device itself. The public record does not identify the predicate device, the specific components or design changes assessed, or any performance data supporting the equivalence finding; those details would reside in the underlying review documents, which are not included here. No clinical, efficacy, or labeling conclusions are drawn from this decision record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 22, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263421
Regulatory pathway
510(k) premarket notification
Applicant
restor3d Inc.
Product code
PHX
Decision code
SESE
Decision date
Oct 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Shoulder Prosthesis, Reverse Configuration.

Applicant
restor3d Inc.
Product code
PHX
FDA device class
2

FDA decision timeline

  1. K263421 received

    Application receipt date recorded by FDA.

  2. K263421 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PHX

Product / regulatory recordCompanyPathwayDecision dateSource
FX Shoulder Solutions, Inc.510(k) clearanceNov 5, 2026FDA
ENCORE MEDICAL, L.P.510(k) clearanceOct 2, 2026FDA
Restor3D510(k) clearanceMay 19, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

restor3d Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Durham, NC

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records